Tower Research Capital (TRC)’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-291
| Closed | -$1K | – | 6667 |
|
|
2023
Q1 | $1K | Buy |
+291
| New | +$862 | ﹤0.01% | 5735 |
|
|
2022
Q4 | – | Sell |
-144
| Closed | -$1K | – | 6792 |
|
|
2022
Q3 | $1K | Buy |
+144
| New | +$1.02K | ﹤0.01% | 5970 |
|
|
2022
Q2 | – | Sell |
-1,193
| Closed | -$13K | – | 6925 |
|
|
2022
Q1 | $13K | Buy |
1,193
+596
| +100% | +$7.6K | ﹤0.01% | 4020 |
|
|
2021
Q4 | $9K | Buy |
597
+98
| +20% | +$2.07K | ﹤0.01% | 4760 |
|
|
2021
Q3 | $12K | Sell |
499
-218
| -30% | -$6.55K | ﹤0.01% | 4193 |
|
|
2021
Q2 | $25K | Buy |
717
+107
| +18% | +$4.25K | ﹤0.01% | 3707 |
|
|
2021
Q1 | $29K | Buy |
610
+118
| +24% | +$6.84K | ﹤0.01% | 3596 |
|
|
2020
Q4 | $24K | Sell |
492
-1,244
| -72% | -$46.8K | ﹤0.01% | 3762 |
|
|
2020
Q3 | $61K | Buy |
1,736
+1,182
| +213% | +$66.6K | ﹤0.01% | 3454 |
|
|
2020
Q2 | $38K | Buy |
554
+216
| +64% | +$8.61K | ﹤0.01% | 3274 |
|
|
2020
Q1 | $8K | Buy |
+338
| New | +$8.09K | ﹤0.01% | 2151 |
|
|
2019
Q4 | – | Sell |
-3,066
| Closed | -$33K | – | 4654 |
|
|
2019
Q3 | $33K | Buy |
3,066
+2,717
| +779% | +$24.2K | ﹤0.01% | 2118 |
|
|
2019
Q2 | $3K | Buy |
349
+58
| +20% | +$590 | ﹤0.01% | 3194 |
|
|
2019
Q1 | $4K | Sell |
291
-402
| -58% | -$4.66K | ﹤0.01% | 3231 |
|
|
2018
Q4 | $6K | Buy |
+693
| New | +$12.1K | ﹤0.01% | 2841 |
|
|
2018
Q3 | – | Sell |
-114
| Closed | -$6K | – | 4401 |
|
|
2018
Q2 | $6K | Buy |
+114
| New | +$5.64K | ﹤0.01% | 3027 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$5K | – | 4033 |
|
|
2017
Q4 | $5K | Sell |
100
-55
| -35% | -$2.92K | ﹤0.01% | 2931 |
|
|
2017
Q3 | $10K | Buy |
+155
| New | +$9.07K | ﹤0.01% | 3088 |
|
|
2017
Q1 | – | Sell |
-58
| Closed | -$9K | – | 4156 |
|
|
2016
Q4 | $9K | Buy |
+58
| New | +$10.3K | ﹤0.01% | 2736 |
|
Tower Research Capital (TRC)'s NH Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 291 shares — an estimated $1K sold.
Tower Research Capital (TRC) first reported a position in NH in Q4 2016 and held it in 19 quarters. The position peaked at $61K in Q3 2020. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 291 NantHealth, Inc shares in Q2 2023, an estimated $1K.
- Tower Research Capital (TRC) first reported a position in NantHealth, Inc in Q4 2016 and held it in 19 quarters.
- Tower Research Capital (TRC)'s NantHealth, Inc position peaked at $61K in Q3 2020.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.